Prozkoumejte nejčtenější články a videa na Campus Sanofi
Clinical insight meets scientific innovation to develop a next generation ERT for Pompe disease Kishnani PS, et al. Mol Genet Metab. 2024;143(1-2):108559.
Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children Domachowske J, Hamrén UW, Banu I, Baronio R, Basavaraju B, Koen A, Leach A, Mankad VS, Pannaraj PS, Soler-Palacin P, Takas T, Mori M, Villafana T, for the MUSIC Study Group.
ALPROLIX has been studied across a range of trials in both adults and children. Here you can read an overview of the publications and access links to the online manuscripts.
Abstract: ATOS y Restore - g: 2 Estudios científicos en satisfacción del tratamiento y análisis del mundo real en pacientes con DT2